SOAT1 expression associates with prognosis, immune environment and biochemical indicators in glioma

Weihua Hu, Wulong Liang, Xuyang Guo, Fangyuan Wang, Zhou Jing, Bingqi Lu, Hao Li, Shaolong Zhou, Ao Huo, Chenglin Zhao, Qingyi Wang, Shipeng Liang, Xudong Fu, Xinjun Wang · 2026

Read SOAT1 expression associates with prognosis, immune environment and biochemical indicators in glioma by Weihua Hu, Wulong Liang, Xuyang Guo, Fangyuan Wang, Zhou Jing, Bingqi Lu, Hao Li, Shaolong Zhou, Ao Huo, Chenglin Zhao, Qingyi Wang, Shipeng Liang, Xudong Fu, Xinjun Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13272719.txt.

Description

Weihua Hu leads a 2026 study of a gene called SOAT1 in glioma, an aggressive brain tumor. The team asked whether levels of this gene track with survival, immune cells in tumors, and blood test results. They used two large glioma databases and a hospital group of 195 patients who had surgery from 2016 to 2020.

SOAT1 levels rose with tumor grade, and high levels meant a worse outlook, even after other factors were counted. High levels also linked to more immune cells in tumors, especially macrophages and neutrophils, and to higher inflammation scores in blood. Salt levels in blood were lower and bilirubin higher in the high group.

Catalog record

CREATORWeihua Hu, Wulong Liang, Xuyang Guo, Fangyuan Wang, Zhou Jing, Bingqi Lu, Hao Li, Shaolong Zhou, Ao Huo, Chenglin Zhao, Qingyi Wang, Shipeng Liang, Xudong Fu, Xinjun Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39448
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13272719

Browse the full library · About the Tower of Babel